GB0221923D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB0221923D0
GB0221923D0 GBGB0221923.6A GB0221923A GB0221923D0 GB 0221923 D0 GB0221923 D0 GB 0221923D0 GB 0221923 A GB0221923 A GB 0221923A GB 0221923 D0 GB0221923 D0 GB 0221923D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0221923.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arrow Therapeutics Ltd
Original Assignee
Arrow Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arrow Therapeutics Ltd filed Critical Arrow Therapeutics Ltd
Priority to GBGB0221923.6A priority Critical patent/GB0221923D0/en
Publication of GB0221923D0 publication Critical patent/GB0221923D0/en
Priority to AU2003267587A priority patent/AU2003267587B2/en
Priority to MXPA05002871A priority patent/MXPA05002871A/en
Priority to NZ570344A priority patent/NZ570344A/en
Priority to CN038251906A priority patent/CN1694874B/en
Priority to KR1020057004751A priority patent/KR101125899B1/en
Priority to US10/528,250 priority patent/US7582624B2/en
Priority to EA200500511A priority patent/EA012387B1/en
Priority to EP03748279A priority patent/EP1539716A1/en
Priority to PL03375860A priority patent/PL375860A1/en
Priority to NZ538870A priority patent/NZ538870A/en
Priority to PCT/GB2003/004050 priority patent/WO2004026843A1/en
Priority to CA2499322A priority patent/CA2499322C/en
Priority to BR0314595-6A priority patent/BR0314595A/en
Priority to JP2004537305A priority patent/JP4719466B2/en
Priority to IL167332A priority patent/IL167332A/en
Priority to ZA2005/02001A priority patent/ZA200502001B/en
Priority to IS7735A priority patent/IS7735A/en
Priority to NO20051908A priority patent/NO20051908L/en
Priority to US12/476,797 priority patent/US8119630B2/en
Priority to JP2010268638A priority patent/JP5298103B2/en
Priority to NO20140629A priority patent/NO20140629L/en
Ceased legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GBGB0221923.6A 2002-09-20 2002-09-20 Chemical compounds Ceased GB0221923D0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
GBGB0221923.6A GB0221923D0 (en) 2002-09-20 2002-09-20 Chemical compounds
JP2004537305A JP4719466B2 (en) 2002-09-20 2003-09-22 Benzodiazepine derivatives and pharmaceutical compositions containing them
NZ538870A NZ538870A (en) 2002-09-20 2003-09-22 Benzodiazepine derivatives and pharmaceutical compositions containing them
CA2499322A CA2499322C (en) 2002-09-20 2003-09-22 Benzodiapine derivatives and pharmaceutical compositions containing them
NZ570344A NZ570344A (en) 2002-09-20 2003-09-22 Benzodiazepine derivatives and pharmaceutical compositions containing them
CN038251906A CN1694874B (en) 2002-09-20 2003-09-22 Benzodiazepine derivatives and pharmaceutical compositions containing them
KR1020057004751A KR101125899B1 (en) 2002-09-20 2003-09-22 Benzodiazepine derivatives and pharmaceutical compositions containing them
US10/528,250 US7582624B2 (en) 2002-09-20 2003-09-22 Benzodiazepine derivatives and pharmaceutical compositions containing them
EA200500511A EA012387B1 (en) 2002-09-20 2003-09-22 Benzodiazepine derivatives and pharmaceutical compositions containing them and use thereof
EP03748279A EP1539716A1 (en) 2002-09-20 2003-09-22 Benzodiazepine derivatives and pharmaceutical compositions containing them
PL03375860A PL375860A1 (en) 2002-09-20 2003-09-22 Benzodiazepine derivatives and pharmaceutical compositions containing them
AU2003267587A AU2003267587B2 (en) 2002-09-20 2003-09-22 Benzodiazepine derivatives and pharmaceutical compositions containing them
PCT/GB2003/004050 WO2004026843A1 (en) 2002-09-20 2003-09-22 Benzodiazepine derivatives and pharmaceutical compositions containing them
MXPA05002871A MXPA05002871A (en) 2002-09-20 2003-09-22 Benzodiazepine derivatives and pharmaceutical compositions containing them.
BR0314595-6A BR0314595A (en) 2002-09-20 2003-09-22 Use of a benzodiazepine derivative or a pharmaceutically acceptable salt thereof, inhaler or nebulizer, product, uses of a product and a compound or pharmaceutically acceptable salt thereof, benzodiazepine derivative, compound, and pharmaceutical composition
ZA2005/02001A ZA200502001B (en) 2002-09-20 2005-03-09 Benzodiazepine derivatives and pharmaceutical compositions containing them
IL167332A IL167332A (en) 2002-09-20 2005-03-09 Use of benzodiazepine derivatives for the preparation of medicaments
IS7735A IS7735A (en) 2002-09-20 2005-03-10 Benzodiazepine derivatives and pharmaceutical compositions containing them.
NO20051908A NO20051908L (en) 2002-09-20 2005-04-19 Chemical connections
US12/476,797 US8119630B2 (en) 2002-09-20 2009-06-02 Benzodiazepine derivatives and pharmaceutical compositions containing them
JP2010268638A JP5298103B2 (en) 2002-09-20 2010-12-01 Benzodiazepine derivatives and pharmaceutical compositions containing them
NO20140629A NO20140629L (en) 2002-09-20 2014-05-19 Chemical connections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0221923.6A GB0221923D0 (en) 2002-09-20 2002-09-20 Chemical compounds

Publications (1)

Publication Number Publication Date
GB0221923D0 true GB0221923D0 (en) 2002-10-30

Family

ID=9944504

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0221923.6A Ceased GB0221923D0 (en) 2002-09-20 2002-09-20 Chemical compounds

Country Status (2)

Country Link
CN (1) CN1694874B (en)
GB (1) GB0221923D0 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201911944D0 (en) * 2019-08-20 2019-10-02 Reviral Ltd Pharmaceutical compounds
GB201915273D0 (en) * 2019-10-22 2019-12-04 Reviral Ltd Pharmaceutical compounds
GB202010408D0 (en) * 2020-07-07 2020-08-19 Reviral Ltd Pharmaceutical compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970207A (en) * 1988-07-07 1990-11-13 Fujisawa Pharmaceutical Company, Ltd. Benzodiazepine derivatives
GB9015879D0 (en) * 1990-07-19 1990-09-05 Fujisawa Pharmaceutical Co Benzodiazepine derivatives
GB9203790D0 (en) * 1992-02-21 1992-04-08 Merck Sharp & Dohme Therapeutic agents
GB2282595A (en) * 1993-08-25 1995-04-12 Yamanouchi Pharma Co Ltd Benzodiazepine derivatives
US5426185A (en) * 1993-11-22 1995-06-20 Merck & Co., Inc. Antiarrhythmic benzodiazepines
FR2716195B1 (en) * 1994-02-14 1996-06-21 Sanofi Sa Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and pharmaceutical compositions containing them
DE69513295T2 (en) * 1994-08-18 2000-06-08 Merck & Co., Inc. 2,3-DIHYDRO-1- (2,2,2-TRIFLUORETHYL) -2-OXO-5-PHENYL-1H-1,4-BENZODIAZEPINE
JP5127096B2 (en) * 1999-04-30 2013-01-23 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン Use of benzodiazepines to treat autoimmune diseases induced by apoptosis
AU2001253090A1 (en) * 2000-04-03 2001-10-15 Bristol-Myers Squibb Pharma Company Cyclic lactams as inhibitors of abeta protein production
GB0012671D0 (en) * 2000-05-24 2000-07-19 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
CN1694874A (en) 2005-11-09
CN1694874B (en) 2010-06-09

Similar Documents

Publication Publication Date Title
GB0209715D0 (en) Chemical compounds
GB0209467D0 (en) Chemical compounds
GB0205165D0 (en) Chemical compounds
GB0205693D0 (en) Chemical compounds
GB0203994D0 (en) Chemical compounds
EG23485A (en) Chemical compounds
PL372538A1 (en) Chemical compounds
AU2003287178A8 (en) Chemical compounds
GB0203020D0 (en) Chemical compounds
GB0205170D0 (en) Chemical compounds
GB0208224D0 (en) Chemical compounds
GB0205176D0 (en) Chemical compounds
GB0205162D0 (en) Chemical compounds
AU2003290661A8 (en) Chemical compounds
GB0207253D0 (en) Chemical compounds
GB0203022D0 (en) Chemical compounds
GB0205690D0 (en) Chemical compounds
AU2003284217A8 (en) Chemical compounds
GB0205175D0 (en) Chemical compounds
GB0205166D0 (en) Chemical compounds
GB0208223D0 (en) Chemical compounds
GB0221923D0 (en) Chemical compounds
GB0205956D0 (en) Chemical compounds
GB0205695D0 (en) Chemical compounds
GB0209463D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)